[1]
Gracia Piquer, R. et al. 2026. Real-world experience with teclistamab in refractory multiple myeloma: efficacy, safety, and pharmacotherapeutic follow-up. Pharmaceutical Care EspaƱa. 28, (Jul. 2026). DOI:https://doi.org/10.60103/phc.v28.e933.